CERVOMED INC (CRVO)
US15713L1098 - Common Stock
ChartMill assigns a Buy % Consensus number of 82% to CRVO. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 54.74. This target is 2637% above the current price.
CRVO was analyzed by 12 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about CRVO.
In the previous month the buy percentage consensus was at a similar level.
CRVO was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-12-17 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-12-11 | Chardan Capital | Downgrade | Buy -> Neutral |
| 2024-12-11 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-12-10 | D. Boral Capital | Downgrade | Buy -> Hold |
| 2024-12-10 | Jones Trading | Downgrade | Buy -> Hold |
| 2024-12-05 | Roth MKM | Initiate | Buy |
| 2024-12-05 | HC Wainwright & Co. | Initiate | Buy |
| 2024-11-27 | D. Boral Capital | Maintains | Buy -> Buy |
| 2024-11-18 | D. Boral Capital | Initiate | Buy |
| 2024-11-14 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-09-18 | Chardan Capital | Initiate | Buy |
| 2024-07-26 | Morgan Stanley | Initiate | Overweight |
| 2024-07-25 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-07-08 | Brookline Capital | Initiate | Buy |
| 2024-05-29 | Jones Trading | Initiate | Buy |
| 2024-04-08 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-02-15 | Canaccord Genuity | Initiate | Buy |